A brain tumour is a growth of abnormal cells in the brain and can affect people of all ages. Not all brain tumors are malignant (cancerous), but even benign (noncancerous) tumours can impact brain function depending on their size and location.
An estimated 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. There are several treatment options for brain tumours.
Brain Tumour programme
Our Brain Tumour Programme is one of the largest and most comprehensive research and treatment programs in the country. This includes the Brain Tumour Research Centre, the interdisciplinary Neuro-Oncology Clinic, the Neurosurgical Simulation and Artificial Intelligence Learning Centre, and collaboration with The Neuro’s Clinical Research Unit which develops clinical trials.
The clinic receives approximately 3,000 patient visits a year and provides the most advanced surgical and oncological treatments available. An interdisciplinary team of surgeons, nurses, oncologists, rehabilitation therapists and social workers is working to improve the care of individuals and families.
The programme offers:
•Diagnostic tools and imaging, such as CT scan, PET scan and MRI
•Specialized surgeries
•Radiotherapy and chemotherapy treatments
• Access to clinical trials of promising new and safe treatments
•Full-time nursing care and social work
•Specialists for your spiritual and psychological needs
•Post-treatment care and rehabilitation with physiotherapists, occupational therapists, speech language therapists and nutritionists according to your needs
•Access to educational and support activities, such as the Network of hope, the Glioma Module, and the Neuro-Patient Resource Centre
The Neuro is at the forefront of brain cancer research. In the past few years, our experts have made several revolutionary discoveries that have changed the course of brain cancer research worldwide. This includes promising drug targets that address brain cancer in its earliest stages, as well as pioneering new effective approaches to surgical treatment.
The Neuro’s bench-to-bedside approach has made these developments possible: our patients provide cells that are analyzed, characterized and stored in our biobank; advanced stem-cell and organoid research allows us to adapt cells as needed to advance research and develop potential drug targets; and our clinical trials unit can test new treatments. We are home to the largest single cell RNA and DNA library in the world: a rich resource for identifying and testing promising new therapies.
The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.
